<DOC>
	<DOCNO>NCT00808093</DOCNO>
	<brief_summary>The purpose study compare effect fast fed condition repeat dos GSK256073F HVT subject .</brief_summary>
	<brief_title>Repeat Dose Food Effect Study GSK256073F Healthy Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Healthy determine responsible physician , base medical evaluation include medical history , physical examination , laboratory test cardiac monitoring . A subject clinical abnormality laboratory parameter outside reference range population study may include Investigator GSK Medical Monitor agree find unlikely introduce additional risk factor interfere study procedure . Male female nonchildbearing potential 18 55 year age . A female subject eligible participate : Nonchildbearing potential define premenopausal female document tubal ligation hysterectomy ; postmenopausal define 12 month spontaneous amenorrhea [ questionable case blood sample simultaneous follicle stimulate hormone ( FSH ) &gt; 40 MlU/ml estradiol &lt; 40 pg/ml ( &lt; 140 pmol/L ) confirmatory ] . Male subject must agree use one contraception method list Section 8.1 . This criterion must follow time first dose study medication 3 day postlast dose . Body weight &gt; 50 kg ( 110 pound ) BMI within range 19 31 kg/m2 ( inclusive ) . Capable give write informed consent , include compliance requirement restriction list consent form . QTcB QTcF &lt; 450 msec The subject positive prestudy drug/alcohol screen . A minimum list drug screen include amphetamine , barbiturate , cocaine , opiates , cannabinoids benzodiazepines A positive prestudy Hepatitis B surface antigen positive Hepatitis C antibody result within 3 month screen . A positive test HIV antibody . History regular alcohol consumption within 6 month study define : An average weekly intake &gt; 14 drinks/week men &gt; 7 drinks/week woman . One drink equivalent ( 12 g alcohol ) = 5 ounce ( 150 ml ) wine 12 ounce ( 360 ml ) beer 1.5 ounce ( 45 ml ) 80 proof distil spirit . The subject participate clinical trial receive investigational product within following time period prior first dose day current study : 30 day , 5 halflives twice duration biological effect investigational product ( whichever longer ) . Exposure four new chemical entity within 12 month prior first dose day . Use prescription nonprescription drug , include vitamin , herbal dietary supplement ( include St John 's Wort ) within 7 day ( 14 day drug potential enzyme inducer ) 5 halflives ( whichever longer ) prior first dose study medication , unless opinion Investigator GSK Medical Monitor medication interfere study procedure compromise subject safety . An exception acetaminophen allow dos ≤ 2g/day . History sensitivity study medication , component thereof history drug allergy , opinion investigator GSK Medical Monitor , contraindicate participation . Where participation study would result donation blood blood product excess 500 mL within 56 day period . Unwillingness inability follow procedure outline protocol . Systolic blood pressure &lt; 100 mmHg ≥ 150 mmHg and/or diastolic blood pressure ≥ 100 mmHg screening . History significant cardiac arrhythmia Active peptic ulcer disease ( PUD ) and/or history PUD within 1 year . Screening test positive H. Pylori use nonradioactive breath test . A serum uric acid concentration ≥ 8mg/dL History gout and/or hyperuricemia History Gilbert 's syndrome A serum creatinine concentration normal reference range History kidney stone PT and/or aPTT reference range History recurrent indigestion , stomach upset diarrhea Liver function test ( LFTs ) creatinine phosphokinase ( CPK ) 2X ULN Screening stool test positive occult blood Screening peripheral blood smear abnormal RBCs Reduced G6PD activity Serum haptoglobin outside reference range screen Total serum LDH &gt; 1.25 % ULN screening Urinary cotinine level indicative smoke history regular use tobacco nicotinecontaining product within 6 month prior screen ( normal reference range 200ng/mL ) . History flushing ( &gt; 1 episode annually ) Fasting blood glucose ≥ 110 mg/dl and/or history type I type II DM History intraocular pathology , include limited retinitis , uveitis , retinal detachment macular edema History recurrent gum bleed History bleeding haemorrhoid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Food Effect</keyword>
	<keyword>GSK256073F</keyword>
	<keyword>TRIS Salt</keyword>
</DOC>